Cited by 267Nanoparticle-Based Drug DeliveryRadiation Therapy and DosimetryLung Cancer Diagnosis and Treatment

The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.

Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer

Open access

Werner, Michael E., Cummings, Natalie D., Sethi, Manish, Wang, Edina C., Sukumar, Rohit, Moore, Dominic T., Wang, Andrew Z.·2013·International Journal of Radiation Oncology*Biology*Physics

DOI 10.1016/j.ijrobp.2013.02.009PMC PMC3750707

Open this paper in CoChat — free account

Abstract

Purpose A key research objective in radiation oncology is to identify agents that can improve chemoradiation therapy. Nanoparticle (NP) chemotherapeutics possess several properties, such as preferential accumulation in tumors, that are uniquely suited for chemoradiation therapy. To facilitate the clinical translation of NP chemotherapeutics in chemoradiation therapy, we conducted preclinical evaluation of Genexol-PM, the only clinically approved NP chemotherapeutic with a controlled drug release profile, as a radiosensitizer using non-small cell lung cancer (NSCLC) as a model disease.Methods and materials The physical characteristics and drug release profile of Genexol-PM were characterized. Genexol-PM's efficacy as a radiosensitizer was evaluated in vitro using NSCLC cell lines and in vivo using mouse xenograft models of NSCLC. Paclitaxel dose to normal lung and liver after Genexol-PM administration were quantified and compared with that after Taxol administration.Results Genexol-PM has a size of 23.91 ± 0.41 nm and surface charge of -8.1 ± 3.1 mV. It releases paclitaxel in a controlled release profile. In vitro evaluation of Genexol-PM as a radiosensitizer showed it is an effective radiosensitizer and is more effective than Taxol, its small molecule counterpart, at the half maximal inhibitory concentration. In vivo study of Genexol-PM as a radiosensitizer demonstrated that it is more effective as a radiosensitizer than Taxol. We also found that Genexol-PM leads to lower paclitaxel exposure to normal lung tissue than Taxol at 6 hours postadministration.Conclusions We have demonstrated that Genexol-PM is more effective than Taxol as a radiosensitizer in the preclinical setting and holds high potential for clinical translation. Our data support the clinical evaluation of Genexol-PM in chemoradiation therapy for NSCLC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2013.02.009

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
Forastiere, A. A., Goepfert, H., Maor, M. H., Pajak, T. F., Weber, R. S., Morrison, W. H., Glisson, B. S., Trotti, A., Ridge, J. A., Chao, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031317 · Cited by 3,161
Analysis of serial measurements in medical research.
Matthews, J. N. S., Altman, D. G., Campbell, M. J., & Royston, P. J. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,137
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J. M., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,685
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,774
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,739
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,575
Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery
O’Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,131
Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study
Fournel, P., Robinet, G., Thomas, P. A., Souquet, P.-J., Léna, H., Vergnenégre, A., Delhoume, J. Y., Treut, J. H. L., Silvani, J.-A., Dansin, É., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.070 · Cited by 543
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 452

Show all 22 references

Sorted by citations

Items 101–200 of 267

Block ionomer micellar nanoparticles from double hydrophilic copolymers, classifications and promises for delivery of cancer chemotherapeutics
Abolmaali, S. S., Tamaddon, A. M., Salmanpour, M., Mohammadi, S., & Dinarvand, R. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.04.009 · Cited by 38
Hypoxia-Responsive Stereocomplex Polymeric Micelles with Improved Drug Loading Inhibit Breast Cancer Metastasis in an Orthotopic Murine Model
Lü, M., Huang, X. P., Cai, X., Sun, J., Liu, X., Weng, L., Zhu, L., Luo, Q., & Chen, Z. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c23737 · Cited by 36
Amphiphilic block copolymers–based micelles for drug delivery
Imran, M., Shah, M. R., & Shafiullah (2018) · Design and Development of New Nanocarriers · doi:10.1016/b978-0-12-813627-0.00010-7 · Cited by 35
Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems
Zhang, P., Tao, H., Yu, L., Zhou, L., & Zhu, C. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1745327 · Cited by 34
Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes
Chaudhari, D., Katari, O., Ghadi, R., Kuche, K., Date, T., Bhargavi, N., & Jain, S. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00594 · Cited by 34
Biomarkers in Ovarian Cancer: Towards Personalized Medicine
López-Portugués, C., Montes‐Bayón, M., & Díez, P. (2024) · Proteomes · doi:10.3390/proteomes12010008 · Cited by 35
Nanoformulations for Glioblastoma Multiforme: A New Hope for Treatment
Ortíz, R., Cabeza, L., Perazzoli, G., Jiménez-López, J., García-Pinel, B., Melguizo, C., & Prados, J. C. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0521 · Cited by 34
Enhanced Cancer Therapy by Combining Radiation and Chemical Effects Mediated by Nanocarriers
Denkova, A. G., Liu, H., Men, Y., & Eelkema, R. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900177 · Cited by 35
Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials
Serras, A. S., Faustino, C. M. C., & Pinheiro, L. M. V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081047 · Cited by 32
Improving chemoradiotherapy with nanoparticle therapeutics.
Eblan, M. J., & Wang, A. Z. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.04 · Cited by 31
Bioinspired poly(cation-π) micelles drug delivery platform for improving chemotherapy efficacy
Tan, G., Wang, Y., He, Y., Miao, G., Li, Y., & Wang, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.016 · Cited by 30
Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine
Kang, C., Wang, J., Li, R., Gong, J., Wang, K., Wang, Y., Wang, Z., He, R., & Li, F. (2023) · Molecules · doi:10.3390/molecules28165955 · Cited by 29
Titanium oxide nano-radiosensitizers for hydrogen peroxide delivery into cancer cells
Morita, K., Nishimura, Y., Nakamura, S., Arai, Y., Numako, C., Sato, K., Nakayama, M., Akasaka, H., Sasaki, R., Ogino, C., et al. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111451 · Cited by 29
Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain
Muresan, P., Woodhams, S. G., Smith, F. N. C., Taresco, V., Shah, J. A., Wong, M., Chapman, V., Smith, S. J., Hathway, G. J., Rahman, R., et al. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102664 · Cited by 29
Supramolecular nanoscale assemblies for cancer diagnosis and therapy
Coelho, S. C., Pereira, M. D. C., Juzeniene, A., Juzenas, P., & Coelho, M. A. N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.034 · Cited by 30
Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
Almeida, D., Gil, J. F., Guillot, A. J., Li, J., Pinto, R. J. B., Santos, H. A., & Gonçalves, G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400946 · Cited by 28
Cancer immunotherapy from biology to nanomedicine
Abdelbaky, S. B., Ibrahim, M. T., Samy, H., Mohamed, M., Mohamed, H., Mustafa, M., Abdelaziz, M. M., Forrest, M. L., & Khalil, I. A. H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.025 · Cited by 28
Recent advancements and future submissions of silica core-shell nanoparticles
Kalyane, D., Kumar, N., Anup, N., Rajpoot, K., Maheshwari, R., Sengupta, P., Kalia, K., & Tekade, R. K. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121173 · Cited by 29
In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts
Sreeranganathan, M., Uthaman, S., Sarmento, B. F. C. C., Mohan, C. G., Park, I., & Jayakumar, R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s143529 · Cited by 26
Casticin Induces DNA Damage and Affects DNA Repair Associated Protein Expression in Human Lung Cancer A549 Cells
Cheng, Z.-Y., Hsiao, Y.-T., Huang, Y., Peng, S., Huang, W.-W., Liu, K.-C., Hsia, T., Way, T., & Chung, J. (2020) · Molecules · doi:10.3390/molecules25020341 · Cited by 26
Polymeric Micelles for Drug Delivery
Wu, W., & Jiang, X. (2016) · Wiley eBooks · doi:10.1002/9783527694396.ch3 · Cited by 27
A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma
You, H., Fu, S., Qin, X., Yu, Y., Yang, B., Zhang, G., Sun, X., Feng, Y., Chen, Y., & Wu, J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.034 · Cited by 25
Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading
Gatti, S., Agostini, A., Palmiero, U. C., Colombo, C., Peviani, M., Biffi, A., & Moscatelli, D. (2018) · Nanotechnology · doi:10.1088/1361-6528/aac0d3 · Cited by 25
Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way
Upadhyay, P., Ghosh, A., Sarangthem, V., & Singh, T. D. (2023) · Phytochemistry Reviews · doi:10.1007/s11101-023-09894-9 · Cited by 25
Triolimus: A Multi‐Drug Loaded Polymeric Micelle Containing Paclitaxel, 17‐AAG, and Rapamycin as a Novel Radiosensitizer
Tomoda, K., Tam, Y. T., Cho, H., Buehler, D. G., Kozak, K. R., & Kwon, G. S. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600194 · Cited by 24
Capacity of gold nanoparticles in cancer radiotherapy
Nagi, N. M. S., Khair, Y. A. M., & Abdalla, A. M. E. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0671-6 · Cited by 24
Transiently Responsive Block Copolymer Micelles Based on N -(2-Hydroxypropyl)methacrylamide Engineered with Hydrolyzable Ethylcarbonate Side Chains
Kasmi, S., Louage, B., Nuhn, L., Driessche, A. V., Deun, J. V., Karalić, I., Risseeuw, M., Calenbergh, S. V., Hoogenboom, R., Rycke, R. M. D., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01252 · Cited by 23
Recent developments in nanocarriers for cancer chemotherapy
Dastidar, D. G., Ghosh, D., & Das, A. K. (2022) · OpenNano · doi:10.1016/j.onano.2022.100080 · Cited by 23
Cisplatin and Albumin-Based Gold–Cisplatin Nanoparticles Enhance Ablative Radiation Therapy–Induced Antitumor Immunity in Local and Distant Tumor Microenvironment
Chen, J. L., Yang, S., Pan, C.-K., Lin, L.-C., Tsai, C.-Y., Wang, C., Huang, Y., Lin, Y., Kuo, S., & Shieh, M. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.02.014 · Cited by 23
Innovative strategies for effective paclitaxel delivery: Recent developments and prospects
Wileński, S., Koper, A., Śledzińska, P., Bebyn, M. G., & Koper, K. (2024) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552231208978 · Cited by 23
Polymeric nanocarriers in drug delivery, bioimaging, and biosensing: advances and perspectives on nanomicelles, nanogels, and dendrimers
Rajabi, M., & Feyzbakhsh, H. (2025) · RSC Advances · doi:10.1039/d5ra05399d · Cited by 31
Amphiphilic tri- and tetra-block co-polymers combining versatile functionality with facile assembly into cytocompatible nanoparticles
Vasey, C. E., Pearce, A. K., Sodano, F., Cavanagh, R. J., Abelha, T. F., Crucitti, V. C., Anane‐Adjei, A. B., Ashford, M. B., Gellert, P., Taresco, V., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00667b · Cited by 26
Targeting CD44-positive ovarian cancers via engineered paclitaxel prodrug nanoparticles for enhanced chemotherapeutic efficacy
Sun, X. Y., Zhao, R., Zhao, E., Wang, Q., Lian, W., & Xiong, J. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113655 · Cited by 22
Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy
Yu, N., Zhang, X., Zhong, H., Mu, J., Li, X., Liu, T., Shi, X., Liang, X., & Guo, S. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03663 · Cited by 22
Junction opener protein increases nanoparticle accumulation in solid tumors
Wang, C. E., Yumul, R., Lin, J., Cheng, Y., Lieber, A., & Pun, S. H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.032 · Cited by 22
Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems
Molinaro, M., Skrodzki, D., & Pan, D. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1984 · Cited by 23
Self-Assembled PAEEP–PLLA Micelles with Varied Hydrophilic Block Lengths for Tumor Cell Targeting
Liu, X., Tan, X., Rao, R., Ren, Y., Li, Y., Yang, X., & Liu, W. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06346 · Cited by 20
In vitroandin vivoevaluation of paclitaxel–lapatinib-loaded F127 pluronic micelles
Dehghankelishadi, P., Saadat, E., Ravar, F., Safavi, M., Pordeli, M., Gholami, M., & Dorkoosh, F. A. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1254238 · Cited by 19
Status and trends in the development of clinical diagnostic agents
Opacic, T., Paefgen, V., Lammers, T., & Kiessling, F. M. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1441 · Cited by 20
Enhancement of radiotherapeutic efficacy for esophageal cancer by paclitaxel-loaded red blood cell membrane nanoparticles modified by the recombinant protein anti-EGFR-iRGD
Ren, W., Sha, H., Yan, J., Wu, P., Yang, J. D., Li, R., Zhang, H., Yu, L., Qian, H., & Liu, B. (2018) · Journal of Biomaterials Applications · doi:10.1177/0885328218809019 · Cited by 18
Protein-based nanocarriers for paclitaxel (PTX) delivery in cancer treatment: A review
Abbaspour, S., Mohamadzadeh, M., & Shojaosadati, S. A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143068 · Cited by 18
Targeted therapies against breast cancer: Clinical perspectives, obstacles and new opportunities
Nagpal, D., Verma, R., Mittal, V., Jeandet, P., & Kaushik, D. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105049 · Cited by 17
Smart thermosensitive copolymer incorporating chitosan–zinc–insulin electrostatic complexes for controlled delivery of insulin: effect of chitosan chain length
Sharma, D., Arora, S., & Singh, J. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2019.1655750 · Cited by 17
Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
Känkänen, V., Seitsonen, J. J. T., Tuovinen, H., Ruokolainen, J., Hirvonen, J. J., Balasubramanian, V., & Santos, H. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119900 · Cited by 17
LRG1-Targeted Camptothecin Nanomicelles with Simultaneous Delivery of Olaparib for Enhanced Colorectal Cancer Chemotherapy
Du, L., Min, H., Meng, Y., Zhang, K., Wang, L., Zhang, Y., Sun, P., Zhang, W., Qi, Y., & Wu, G. (2025) · Nano Letters · doi:10.1021/acs.nanolett.4c05354 · Cited by 18
Increasing the Therapeutic Efficacy of Radiotherapy Using Nanoparticles
Zaki, A. A., Cormode, D. P., Tsourkas, A., & Dorsey, J. F. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-40854-5_10 · Cited by 16
Surface Modification of Nanoparticles to Oppose Uptake by the Mononuclear Phagocyte System
Parmar, K. R., & Patel, J. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-06115-9_12 · Cited by 16
“Nano-Paclitaxel” Unlocking Potential and Redefining Cancer Chemotherapy
Muley, A., Navale, A., Gupta, R., & Tekade, R. K. (2025) · ACS Omega · doi:10.1021/acsomega.5c02916 · Cited by 15
Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer
Huang, M., Teng, Q., Cao, F., Huang, J., & Pang, J. (2024) · Biomaterials Science · doi:10.1039/d3bm01894f · Cited by 15
Functionalized Block Co‐Polymer Pro‐Drug Nanoparticles with Anti‐Cancer Efficacy in 3D Spheroids and in an Orthotopic Triple Negative Breast Cancer Model
Taresco, V., Abelha, T. F., Cavanagh, R. J., Vasey, C. E., Anane‐Adjei, A. B., Pearce, A. K., Monteiro, P. F., Spriggs, K. A., Clarke, P. A., Ritchie, A., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000103 · Cited by 19
Targeting chemo-proton therapy on C6 cell line using superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel
Kang, S. H., Hong, S. P., & Kang, B. S. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1495854 · Cited by 16
Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor
Zeng, Y., Liu, F., Wang, J., Shao, B., He, T., Xiang, Z., Wang, Y., Zhu, S., Yang, T., Yu, S., et al. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109734 · Cited by 14
Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks
Mohammad-Jafari, K., Naghib, S. M., & Mozafari, M. R. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128304923240704113319 · Cited by 14
Advances in paclitaxel nanoformulations: A systematic review of in vivo therapeutic efficacy and safety enhancements
Seyam, S., Alallam, B., Fadzilah, N. H., & Kadir, E. A. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114036 · Cited by 13
Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology
Mendes, R. G. P. R., Carreira, B., Baptista, P. V., & Fernandes, A. R. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1159914 · Cited by 15
Prominin-1-Specific Binding Peptide-Modified Apoferritin Nanoparticle Carrying Irinotecan as a Novel Radiosensitizer for Colorectal Cancer Stem-Like Cells
Chen, J. L., Tsai, Y.-C., Tsai, M.-H., Lee, S., Wei, M., Kuo, S., & Shieh, M. (2017) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201600424 · Cited by 13
Lipid and Polymeric Nanoparticles: Drug Delivery Applications
Rezigue, M. M. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_7 · Cited by 13
Structural Modifications in Polymeric Micelles to Impart Multifunctionality for Improved Drug Delivery
Mittal, A., & Chitkara, D. (2016) · Therapeutic Delivery · doi:10.4155/tde.15.90 · Cited by 13
Synthesis of Polyethylene Glycol–Poly(glycerol carbonate) Block Copolymeric Micelles as Surfactant-Free Drug Delivery Systems
Fitzgerald, D. M., Zhang, H., Bordeianu, C., Colson, Y. L., & Grinstaff, M. W. (2023) · ACS Macro Letters · doi:10.1021/acsmacrolett.3c00275 · Cited by 12
RNA-Seq-guided triple-combination nano-system of gold nanocluster, quercetin, and docetaxel for ultimate synergistic photothermal-chemotherapy against MDR tumor
Shin, Y., Kim, M., Lee, E. S., Lim, C., & Oh, K. T. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101862 · Cited by 12
Reinvention of chemotherapy
Nguyen‐Ngoc, T., & Raymond, É. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000183 · Cited by 12
Sorafenib-fortified zein–chondroitin sulphate biopolymer nanoparticles as a novel therapeutic system in gastric cancer treatment
Cheng, H., Hsieh, S., Chen, T., Hung, P.-F., & Pan, S. (2016) · RSC Advances · doi:10.1039/c6ra06775a · Cited by 12
Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokinetics
Wang, Q., Wei, N., Liu, X., Chang, A., & Luo, K. Q. (2017) · Oncotarget · doi:10.18632/oncotarget.14481 · Cited by 12
Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations
Lee, J., Choi, M., & Song, I. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01609-w · Cited by 12
Polymeric Micelles in Targeted Breast Cancer Therapy：Recent Advances and Future Trends
Soni, A., & Jaiswal, V. P. (2025) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2025.9290122 · Cited by 14
Nanomedicines and Nanodrug Delivery Systems: Trends and Perspectives
Das, S., Das, M. K., Deka, T., Singha, L. R., & Das, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6255-6_6 · Cited by 11
Emerging Nanotheranostics for 5-Fluorouracil in Cancer Therapy: A Systematic Review on Efficacy, Safety, and Diagnostic Capability
How, C. W., Teoh, S. L., Loh, J. S., Tan, L., Foo, J. B., Ng, H. S., Wong, S. Y. W., & Ong, Y. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.882704 · Cited by 11
Nanotherapies from an oncologist doctor's view
Liu, S., Li, L., Zhang, X., & Meng, Q. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.07.005 · Cited by 11
Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics
Alnatour, M., Abdelrazig, S., Ghaemmaghami, A. M., Alexander, C., & Kim, D. (2022) · ACS Omega · doi:10.1021/acsomega.2c01660 · Cited by 11
Recent Trends in the Development and Clinical Translation of Polymer-based Targeted Therapeutic Nanoparticle
Singh, C. K., Bania, R., Deka, S., Dwivedi, M., Nair, A. B., Bal, T., Maity, P., & Deb, P. K. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-025-03319-w · Cited by 12
Fundamentals to clinical application of nanoparticles in cancer immunotherapy and radiotherapy
Selvaraj, V. K., & Gudipudi, D. K. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1095 · Cited by 10
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
Schunke, J., Mailänder, V., Landfester, K., & Fichter, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512174 · Cited by 11
Diblock and triblock copolymers of polylactide and polyglycolide
Sharma, D., Lipp, L., Arora, S., & Singh, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816874-5.00013-x · Cited by 10
Intermolecular Interactions between Coencapsulated Drugs Inhibit Drug Crystallization and Enhance Colloidal Stability of Polymeric Micelles
Zhang, L., Sun, H., Chen, Z., Liu, Z., Huang, N., & Qian, F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00591 · Cited by 9
Current approaches to overcome the limit of TRAIL-based treatment in colorectal cancer: From fusion protein to nano-delivery platform
Chen, X., Yang, X., Chen, X., Cheng, Y., & Li, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126031 · Cited by 9
Lipid-assisted PEG- b -PLA nanoparticles with ultrahigh SN38 loading capability for efficient cancer therapy
Huang, X., Li, J., Yang, Y., Wang, Z., Yang, X., Lu, Z.-D., & Xu, C. (2023) · Biomaterials Science · doi:10.1039/d3bm01469j · Cited by 8
Application of nano-radiosensitizers in non-small cell lung cancer
Hu, X., Hu, J., Pang, Y., Wang, M., Zhou, W., Xie, X., Zhu, C., Wang, X., & Sun, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1372780 · Cited by 8
Radionanotheranostics for breast cancer diagnosis and therapy: recent advances and future opportunities
Mehata, A. K., Viswanadh, M. K., Solomon, V. R., & Muthu, M. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824476-0.00018-8 · Cited by 8
Nanopharmacy: Exploratory Methods for Polymeric Materials
Bansal, K. K., Sasso, L., Makwana, H., Awwad, S., Brocchini, S., & Alexander, C. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch10 · Cited by 8
Polymeric nanoparticles for potential drug delivery applications in cancer
Fatima, S., Quadri, S. N., Parveen, S., Beg, S., Rahman, M., Ahmad, F. J., & Abdin, M. Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821095-6.00009-4 · Cited by 8
Formulation effects on paclitaxel transfer and uptake in the human placenta
Ali, S., Albekairi, N. A., Al-Enazy, S., Shah, M. K., Patrikeeva, S., Nanovskaya, T. N., Ahmed, M. S., & Rytting, E. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102354 · Cited by 7
Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs
Yılmaz, C., Sarısözen, C., Torchilin, V. P., & BUSNAINA, A. A. (2016) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-12-3-157 · Cited by 7
Acrylamides with hydrolytically labile carbonate ester side chains as versatile building blocks for well-defined block copolymer micelles via RAFT polymerization
Kasmi, S., Louage, B., Nuhn, L., Verstraete, G., Herck, S. V., van Steenbergen, M. J., Vervaet, C., Hennink, W. E., & Geest, B. G. D. (2017) · Polymer Chemistry · doi:10.1039/c7py01345k · Cited by 7
Polymeric micelles as a versatile tool in oral chemotherapy
Ribeiro, A. M., Amaral, C., Veiga, F., & Figueiras, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00008-9 · Cited by 7
Evaluation of the risk and benefit of using functionalized nanomaterials as contrast agents in image-guided radiotherapy: a Monte Carlo study on the imaging dose and contrast enhancement
Chow, J. C. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822415-1.00014-7 · Cited by 7
Overview of Optical Fiber Biosensors for the Detection of Cancer Biomarkers in the Past Decade
Vikas, V., Mishra, A. K., Verma, R. K., & Saccomandi, P. (2026) · ACS Omega · doi:10.1021/acsomega.6c00722 · Cited by 6
Developing a novel P-glycoprotein inhibitor and pairing it with oral paclitaxel liposomes for enhanced cancer therapy
Deng, S., Li, W., Chen, Q., Shao, J., Zhang, J., Wang, Y., & Li, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117577 · Cited by 6
Nano-oncology: Clinical Application for Cancer Therapy and Future Perspectives
Singh, P., & Sahoo, S. K. (2021) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-76263-6_3 · Cited by 7
Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
Demuytere, J., Carlier, C., de Sande, L. V., Hoorens, A., Clercq, K. D., Giordano, S., Morosi, L., Matteo, C., Zucchetti, M., Davoli, E., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s424045 · Cited by 5
Metronomic paclitaxel-loaded mPEG–PLA nanoparticles show enhanced anti-tumor efficacy compared to maximum tolerated dose administration
Tan, F., Yang, L., Mo, X., Wang, X., & Gu, J. F. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2706-6 · Cited by 5
Preparation and Evaluation of Folate Modified PEG-PLLA Nanoparticles Loaded with Lycorine for Glioma Treatment
Ding, J., Su, J., Luo, B., & Ding, L. (2024) · Molecules · doi:10.3390/molecules29051081 · Cited by 5
Neoantigen activation, Protein Translocation and Targeted Drug Delivery in Combination With Radiotherapy
Sethuraman, S. N., & Ranjan, A. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0005 · Cited by 5
Nanomedicines in Cancer Therapy
Abu-Qudais, E., Chandrasekaran, B., Samarneh, S., & Kassab, G. H. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_12 · Cited by 5
The Quality Control of Micro- and Nanomedicines: Compliance with Regulatory Guidelines
Li, L., Wu, W., Le, J., & Lü, Y. (2025) · Pharmaceutical Fronts · doi:10.1055/a-2571-1493 · Cited by 5
Evaluation of a novel liposome nano-formulation of quercetin with optimized cholesterol level [Lipo-Que] for intravenous administration and in vivo toxicity in mice
Jenitha, V., Wilson, D., Gnanaselvam, M., Babu, K. N., Ramachandran, Viswanathan, S., Srividhya, Nandana, V., & Grace, V. M. B. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.107984 · Cited by 4
SmartLipids in Drug Delivery: Redefining the Third Generation of Lipid Nanocarriers for Clinical and Industrial Translation
Hashmi, A. R., Zahra, F., Sekar, M., Hamod, M. A., Hamood, N. A., Begum, M. Y., Molugulu, N., Wong, L., & Kumarasamy, V. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s578218 · Cited by 4
Advances in Parenteral Nanocarriers and Delivery Devices: A Comprehensive Review
Kapoor, D. U., Prajapati, B. G., Bhattacharya, S., Singhai, N. J., & Maheshwari, R. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128338217250114073640 · Cited by 6
Leveraging Recent Advances in Self‐Assembled Polysaccharide‐Based Delivery Systems in Therapeutics: A Review of Key Properties and Strategies
Karmakar, P. D., & Pal, A. (2025) · Polymer Engineering and Science · doi:10.1002/pen.70120 · Cited by 4
Review of commercially available nano-drugs and nano-delivery systems: challenges and perspectives
Boudovitch, D., Sakaya, A., Uzundurukan, A., Leroux, J.-Y., & Fuoco, D. (2023) · 4open · doi:10.1051/fopen/2024002 · Cited by 4
Natural polymers for diagnosis and treatment of cancers
Mehrabi, A., Najafloo, R., Valizadeh, H., Sarmadi, V. H., Naderi, S., Faghihebadi, G., & Milan, P. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85661-4.00017-2 · Cited by 4

Authors: Werner, M. E., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D. T., & Wang, A. Z.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Wang, Andrew Z.
ORCID: Werner, Michael E.
Sethi, Manish
Wang, Edina C.
Wang, Andrew Z.
Venue: International Journal of Radiation Oncology*Biology*Physics
Publisher: Elsevier BV
Published: 2013-07
Volume: 86
Issue: 3
Pages: 463-468
ISSN: 0360-3016 (ISSN-L)
DOI: 10.1016/j.ijrobp.2013.02.009
PMC: PMC3750707
OpenAlex: W2169498622
Cited by: 267
References: 22
Citations by year: 2026: 20 · 2025: 23 · 2024: 21 · 2023: 31 · 2022: 24 · 2021: 18 · 2020: 23 · 2019: 18 · 2018: 23 · 2017: 19 · 2016: 22 · 2015: 12 · 2014: 8 · 2013: 4
FWCI: 5.85
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: International Journal of Radiation Oncology*Biology*Physics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5u54ca151652-05, 2k12ca120780-16)
National Cancer Institute (5-K12-CA120780-01-05, U54‐CA151652, 1-U54-CA151652-01, K12-CA120780, R01CA178748)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords: paclitaxel, nanoparticle drug delivery, radiosensitizers, non-small cell lung cancer, chemoradiotherapy, controlled drug release, nanoparticle size and surface charge, taxol comparison
MeSH terms: Animals, Antineoplastic Agents, Phytogenic, Carcinoma, Non-Small-Cell Lung, Lung, Lung Neoplasms, Mice, Nude, Polymers, Radiation-Sensitizing Agents, Paclitaxel, Xenograft Model Antitumor Assays, Cell Line, Tumor, Tumor Burden, Mice, Nanoparticles, Chemoradiotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks